Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph A Ludwig

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Current Opinion in Oncology|June 6, 2008
Ewing sarcoma: historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the futureJoseph A Ludwig
Current Oncology Reports|September 10, 2008
Personalized therapy of sarcomas: integration of biomarkers for improved diagnosis, prognosis, and therapy selectionJoseph A Ludwig
Clinical Advances in Hematology & Oncology : H&O|September 25, 2010
Review: Ewing sarcoma treatment: a role for bisphosphonates?Vivek Subbiah, Joseph A Ludwig
Nature Reviews. Cancer|October 22, 2005
Biomarkers in cancer staging, prognosis and treatment selectionJoseph A Ludwig, John N Weinstein
Journal of Bone Oncology|May 6, 2022
Commentary: A Special Edition in bone sarcomaJoseph A Ludwig, Brian Van Tine
The New England Journal of Medicine|April 14, 2021
Ewing's SarcomaJoseph A Ludwig, Paul A Meyers, Uta Dirksen
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Understanding sarcoma drug resistance one cell at a timeSalah-Eddine Cherradi-Lamhamedi, Danh Truong, Joseph A Ludwig
Current Treatment Options in Oncology|June 19, 2025
Desmoplastic Small Round Cell Tumors and the Role of Androgen ReceptorsDanh D Truong, Roberto Cardenas-Zuniga, Joseph A Ludwig
Journal of Bone Oncology|March 7, 2022
Targeting the IGF/PI3K/mTOR pathway and AXL/YAP1/TAZ pathways in primary bone cancerDanh D Truong, Salah-Eddine Lamhamedi-Cherradi, Joseph A Ludwig
Tissue Engineering. Part B, Reviews|January 23, 2010
Engineering tumors: a tissue engineering perspective in cancer biologyEmily Burdett, F Kurtis Kasper, Antonios G Mikos, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Current Opinion in Oncology|June 6, 2008
Ewing sarcoma: historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the futureJoseph A Ludwig
Current Oncology Reports|September 10, 2008
Personalized therapy of sarcomas: integration of biomarkers for improved diagnosis, prognosis, and therapy selectionJoseph A Ludwig
Clinical Advances in Hematology & Oncology : H&O|September 25, 2010
Review: Ewing sarcoma treatment: a role for bisphosphonates?Vivek Subbiah, Joseph A Ludwig
Nature Reviews. Cancer|October 22, 2005
Biomarkers in cancer staging, prognosis and treatment selectionJoseph A Ludwig, John N Weinstein
Journal of Bone Oncology|May 6, 2022
Commentary: A Special Edition in bone sarcomaJoseph A Ludwig, Brian Van Tine
The New England Journal of Medicine|April 14, 2021
Ewing's SarcomaJoseph A Ludwig, Paul A Meyers, Uta Dirksen
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Understanding sarcoma drug resistance one cell at a timeSalah-Eddine Cherradi-Lamhamedi, Danh Truong, Joseph A Ludwig
Current Treatment Options in Oncology|June 19, 2025
Desmoplastic Small Round Cell Tumors and the Role of Androgen ReceptorsDanh D Truong, Roberto Cardenas-Zuniga, Joseph A Ludwig
Journal of Bone Oncology|March 7, 2022
Targeting the IGF/PI3K/mTOR pathway and AXL/YAP1/TAZ pathways in primary bone cancerDanh D Truong, Salah-Eddine Lamhamedi-Cherradi, Joseph A Ludwig
Tissue Engineering. Part B, Reviews|January 23, 2010
Engineering tumors: a tissue engineering perspective in cancer biologyEmily Burdett, F Kurtis Kasper, Antonios G Mikos, et al.
Pageof 7